Stryker will report Q4 and full year 2025 financial results on January 29, 2026, with a subsequent webcast.
Quiver AI Summary
Stryker announced that it will release its financial results for the fourth quarter and full year of 2025 on January 29, 2026. The press release will be available around 4:05 p.m. ET and will detail summary financial information for the periods ending December 31, 2025. Following the release, Stryker will hold a webcast at 4:30 p.m. ET to discuss these results, accessible on their website. An archive of the webcast will be available shortly after the live event. Stryker is a leader in medical technology, aiming to improve healthcare outcomes with innovative products and services. For further inquiries, investors and media can contact designated representatives at Stryker.
Potential Positives
- Stryker is announcing a scheduled financial results report for Q4 and full year 2025, indicating transparency and accountability to its investors.
- The upcoming webcast will facilitate direct communication with stakeholders, allowing them to engage with the company's performance and strategy.
- Stryker highlights its position as a global leader in medical technologies, emphasizing its impact on over 150 million patients annually, which reinforces its reputation and market presence.
- The company's commitment to innovative products and services in vital medical sectors showcases its dedication to improving healthcare outcomes, potentially attracting more investment and partnerships.
Potential Negatives
- None
FAQ
When will Stryker release its financial results for Q4 2025?
Stryker will release its financial results for Q4 2025 on January 29, 2026.
What time is the Stryker financial results press release?
The press release will be issued at approximately 4:05 p.m. ET on January 29, 2026.
How can I access Stryker's financial results webcast?
The webcast can be accessed at Stryker - Events & Presentations at 4:30 p.m. ET on January 29, 2026.
Will there be an archive of the financial results webcast?
Yes, an archive of the webcast will be available on Stryker's website two hours after the live call ends.
What products and services does Stryker offer?
Stryker offers innovative products and services in MedSurg, Neurotechnology, and Orthopaedics.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SYK Insider Trading Activity
$SYK insiders have traded $SYK stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $SYK stock by insiders over the last 6 months:
- RONDA E STRYKER has made 0 purchases and 22 sales selling 720,000 shares for an estimated $259,895,796.
- WILLIAM E JR BERRY (VP, Chief Accounting Officer) sold 1,953 shares for an estimated $713,801
- ROBERT S FLETCHER (VP, Chief Legal Officer) sold 1,785 shares for an estimated $701,629
- VIJU MENON (Group President) sold 500 shares for an estimated $195,305
- PRESTON WENDELL WELLS (VP, Chief Financial Officer) sold 165 shares for an estimated $60,370
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SYK Revenue
$SYK had revenues of $6.1B in Q3 2025. This is an increase of 10.25% from the same period in the prior year.
You can track SYK financials on Quiver Quantitative's SYK stock page.
$SYK Congressional Stock Trading
Members of Congress have traded $SYK stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $SYK stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 4 times. They made 0 purchases and 4 sales worth up to $165,000 on 11/20, 09/12, 08/25, 07/31.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$SYK Hedge Fund Activity
We have seen 1,012 institutional investors add shares of $SYK stock to their portfolio, and 908 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 2,009,275 shares (-28.1%) from their portfolio in Q3 2025, for an estimated $742,768,689
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,372,934 shares (+59.5%) to their portfolio in Q3 2025, for an estimated $507,532,511
- CORIENT PRIVATE WEALTH LLC removed 1,295,848 shares (-57.7%) from their portfolio in Q3 2025, for an estimated $479,036,130
- PRICE T ROWE ASSOCIATES INC /MD/ removed 900,546 shares (-7.6%) from their portfolio in Q3 2025, for an estimated $332,904,839
- ROYAL BANK OF CANADA added 876,538 shares (+35.6%) to their portfolio in Q3 2025, for an estimated $324,029,802
- SQUAREPOINT OPS LLC added 757,411 shares (+3842.4%) to their portfolio in Q3 2025, for an estimated $279,992,124
- ALLIANCEBERNSTEIN L.P. added 741,542 shares (+13.3%) to their portfolio in Q3 2025, for an estimated $274,125,831
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SYK Analyst Ratings
Wall Street analysts have issued reports on $SYK in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 11/14/2025
- BTIG issued a "Buy" rating on 11/14/2025
- Barclays issued a "Overweight" rating on 10/22/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- Needham issued a "Buy" rating on 08/01/2025
To track analyst ratings and price targets for $SYK, check out Quiver Quantitative's $SYK forecast page.
$SYK Price Targets
Multiple analysts have issued price targets for $SYK recently. We have seen 9 analysts offer price targets for $SYK in the last 6 months, with a median target of $420.0.
Here are some recent targets:
- David Turkaly from Citizens set a target price of $440.0 on 12/19/2025
- Richard Newitter from Truist Securities set a target price of $392.0 on 12/18/2025
- Joanne Wuensch from Citigroup set a target price of $420.0 on 12/11/2025
- Ryan Zimmerman from BTIG set a target price of $410.0 on 11/14/2025
- Mike Matson from Needham set a target price of $448.0 on 11/14/2025
- Larry Biegelsen from Wells Fargo set a target price of $456.0 on 11/14/2025
- Vijay Kumar from Evercore ISI Group set a target price of $405.0 on 10/31/2025
Full Release
Portage, Michigan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its fourth quarter and full year 2025 on Thursday, January 29, 2026. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s fourth quarter and full year that ended December 31, 2025.
Stryker will host a webcast at 4:30 p.m. ET on Thursday, January 29, 2026, to discuss its fourth quarter and full year 2025 results. The webcast can be accessed at Stryker - Events & Presentations . An archive of the webcast will also be available on the company's website two hours after the live call ends.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or
[email protected]
For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or
[email protected]
